Short review highlights the effectiveness of newborn hearing screening in identifying congenital deafness, suggesting significant implications for neurocognitive development.
Newborn hearing screening is the best strategy to identify congenital deafness and hearing loss. The incidence of sensorineural hearing loss is 3 per 1000 for term newborns and up to 4 per 100 for newborns hospitalized in the NICU, therefore identification up to a maximum of 6 months has an optimal effect on neurocognitive development. Auditory testing techniques have evolved since the 1800s and currently include transient evoked otoacoustic emissions (TEOAE), distortion product otoacoustic emissions (DPOAE), the automated auditory brainstem response (ABR) or a combination of them. In our country we use auditory brainstem response (ABR) and otoacoustic emissions (OAE), thus we can identify up to 85% of hearing loss in the first 6 months of life.
No takes yet. Share an insight, caveat, or question.
Calomfirescu‐Avramescu et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: